Ambu A/S

CPSE:AMBU B Lagerbericht

Marktkapitalisierung: DKK 17.6b

Ambu Ausschüttungen und Rückkäufe

Zukünftiges Wachstum Kriterienprüfungen 0/6

Ambu ist ein dividendenzahlendes Unternehmen mit einer aktuellen Rendite von 0.61%.

Wichtige Informationen

0.6%

Dividendenausschüttung

0.9%

Rückkaufsrendite

Gesamte Aktionärsrendite1.5%
Zukünftige Dividendenrendite1.1%
Wachstum der Dividende3.7%
Nächster Dividendenzahlungsterminn/a
Ex-Dividendendatumn/a
Dividende pro Aktien/a
Ausschüttungsquote23%

Jüngste Updates zu Dividenden und Rückkäufen

Recent updates

Narrativ-Update May 19

AMBU B: Lower P/E Expectations Will Support Future Upside Repricing

Analysts have trimmed their price target on Ambu from DKK 110.34 to DKK 88.80, reflecting a more cautious stance following a downgrade in recent research. The revised target still assumes steady revenue growth and a lower future P/E multiple.
Analyseartikel May 09

Ambu A/S Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next

As you might know, Ambu A/S ( CPH:AMBU B ) last week released its latest quarterly, and things did not turn out so...
Narrativ-Update May 04

AMBU B: Higher Growth And Margins Are Expected To Support Future Upside

Analysts have reduced their price target on Ambu by DKK 12. This reflects updated views on discount rates, expected revenue growth, profit margins and future P/E assumptions.
Narrativ-Update Apr 20

AMBU B: Reset P/E Assumptions Will Support Future Upside Repricing

Ambu's analyst price target has been reduced by DKK 12 to reflect updated views on its P/E assumptions, revenue growth profile and profitability, with analysts pointing to the recent DKK 12 target cut cited in Street research. Analyst Commentary JPMorgan's DKK 12 reduction in its Ambu price target reflects a reset of P/E expectations and a more cautious stance on the company's revenue growth and profitability profile.
Narrativ-Update Apr 06

AMBU B: Refined Discount Rate And P/E Expectations Will Support Future Upside

Analysts have lowered their price target on Ambu by DKK 12. This reflects small adjustments to fair value, discount rate, revenue growth, profit margin and future P/E assumptions following recent research updates.
Narrativ-Update Mar 22

AMBU B: Lower P/E Assumptions Will Support Upside If Execution Improves

Analysts have lowered their price target on Ambu by DKK 12 to reflect slightly adjusted assumptions on fair value, discount rate, revenue growth, profit margin, and future P/E following the recent JPMorgan target cut to DKK 12. Analyst Commentary Bullish Takeaways Bullish analysts see the revised fair value and discount rate assumptions as a reset that could leave room for upside if Ambu delivers on its operational targets.
Narrativ-Update Mar 08

AMBU B: Share Repurchase Mandate And Lowered Fair Value Will Support Upside

Analysts have trimmed their price target on Ambu by DKK 12 to reflect updated assumptions on fair value, discount rates and earnings expectations following recent research commentary. Analyst Commentary Bullish Takeaways Bullish analysts view the revised DKK 12 lower price target as still consistent with a supportive fair value range.
Narrativ-Update Feb 22

AMBU B: Share Buybacks And Margin Discipline Will Support Future Upside

The analyst price target for Ambu has been trimmed by DKK 1 to DKK 138, as analysts factor in slightly more cautious assumptions on growth, margins and discount rates following recent price target adjustments, such as the DKK 12 cut highlighted by JPMorgan. Analyst Commentary Bullish analysts remain focused on how Ambu can justify its current valuation through consistent execution on its growth plans, even as some price targets, including the DKK 12 adjustment flagged by JPMorgan, are recalibrated.
Narrativ-Update Feb 08

AMBU B: Higher Risk Premium And Margin Pressure Will Reshape Share Outlook

The analyst price target for Ambu has been reduced from DKK 94.54 to DKK 78.00. This change reflects analysts’ updated assumptions on discount rate, revenue growth, profit margin and future P/E, as highlighted by recent Street research including a DKK 12 target cut.
Analyseartikel Feb 08

Earnings Miss: Ambu A/S Missed EPS By 8.7% And Analysts Are Revising Their Forecasts

Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 3.3% to close at kr.87.90 following the...
Narrativ-Update Jan 25

AMBU B: Share Repurchases And Dividend Policy Will Support Future Upside

Analysts have slightly reduced their price target on Ambu, citing modest revisions to fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. Together, these changes support a more cautious yet still constructive view on the shares.
Narrativ-Update Jan 11

AMBU B: Share Buybacks And Dividend Policy Will Support Future Upside

Analysts now set Ambu's price target at €139, down from €147, citing updated assumptions for discount rates, revenue growth, profit margins and future P/E that adjust their valuation framework. What's in the News Ambu A/S is set to be removed from the OMX Copenhagen 20 Index, which may affect how some index and benchmark focused investors view or hold the stock (Key Developments).
Analyseartikel Jan 03

Ambu A/S' (CPH:AMBU B) Price In Tune With Earnings

With a price-to-earnings (or "P/E") ratio of 37.7x Ambu A/S ( CPH:AMBU B ) may be sending very bearish signals at the...
Narrativ-Update Dec 19

AMBU B: Dividend And Share Buybacks Will Drive Future Upside Potential

Analysts have trimmed their price target for Ambu slightly, lowering fair value by about 1 dollar per share as modestly slower expected revenue growth and profit margins are only partly offset by a slightly higher future P/E multiple and lower discount rate. What's in the News Ambu has launched a new share repurchase program starting December 10, 2025, allowing buybacks of up to 10% of its share capital under a mandate valid until December 13, 2027 (company announcement) The company announced an annual dividend of DKK 0.41 per share, payable on December 8, 2025, with an ex date of December 4 and record date of December 5, 2025 (company announcement) For fiscal 2025/26, Ambu issued guidance for 10% to 13% organic growth and an EBIT margin of 12% to 14%, or 14% to 16% excluding roughly 2 percentage points of tariff impacts (company guidance) Ambu reaffirmed its 2024/25 financial guidance, maintaining expectations for 12% to 14% organic revenue growth (company guidance) Valuation Changes Fair Value Estimate edged down slightly from DKK 115.59 to DKK 114.79 per share, reflecting a modestly lower fundamental valuation.
Analyseartikel Dec 12

An Intrinsic Calculation For Ambu A/S (CPH:AMBU B) Suggests It's 34% Undervalued

Key Insights Using the 2 Stage Free Cash Flow to Equity, Ambu fair value estimate is kr.130 Ambu's kr.85.60 share price...
Narrativ-Update Dec 05

AMBU B: Dividend Initiation And Margin Outlook Will Support Future Upside

Analysts have modestly raised their price target on Ambu by DKK 0.00 to reflect a slightly higher discount rate and updated profitability assumptions, while maintaining largely unchanged views on long term growth and valuation multiples. What's in the News Ambu A/S announced an annual dividend of DKK 0.41 per share, payable on December 8, 2025, with ex-date December 4 and record date December 5, 2025 (Key Developments).
Analyseartikel Nov 27

We Think Shareholders Are Less Likely To Approve A Pay Rise For Ambu A/S' (CPH:AMBU B) CEO For Now

Key Insights Ambu's Annual General Meeting to take place on 3rd of December Salary of kr.8.01m is part of CEO Britt...
Narrativ-Update Nov 21

AMBU B: Improved Margins And Dividend Outlook Will Support Bullish Momentum

Analysts have slightly lowered their fair value price target for Ambu from DKK 121.41 to DKK 115.59, citing modest decreases in projected revenue growth and profit margin expectations. What's in the News Ambu A/S announced an annual dividend of DKK 0.4100 per share.
Narrativ-Update Nov 06

AMBU B: Higher Profit Margins Will Drive Hospital Efficiency Improvements

Analysts have revised their fair value estimate for Ambu down from DKK 130.70 to DKK 121.41. They cite a slightly higher discount rate, even though profit margin and revenue growth projections have improved.
Analyseartikel Oct 07

Ambu (CPH:AMBU B) Has More To Do To Multiply In Value Going Forward

To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...
Analyseartikel Aug 27

Ambu A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 3.4% to close at kr.98.20 following the...
Analyseartikel Aug 11

Is Ambu A/S (CPH:AMBU B) Trading At A 35% Discount?

CPSE:AMBU B 1 Year Share Price vs Fair Value Explore Ambu's Fair Values from the Community and select yours Key...
Analyseartikel Jul 12

Should You Think About Buying Ambu A/S (CPH:AMBU B) Now?

Ambu A/S ( CPH:AMBU B ), is not the largest company out there, but it saw significant share price movement during...
Analyseartikel May 15

Ambu's (CPH:AMBU B) Earnings Offer More Than Meets The Eye

The stock was sluggish on the back of Ambu A/S' ( CPH:AMBU B ) recent earnings report. We have done some analysis, and...
Analyseartikel Mar 14

Is Now The Time To Put Ambu (CPH:AMBU B) On Your Watchlist?

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Analyseartikel Feb 02

Earnings Miss: Ambu A/S Missed EPS By 6.2% And Analysts Are Revising Their Forecasts

Ambu A/S ( CPH:AMBU B ) last week reported its latest quarterly results, which makes it a good time for investors to...
Analyseartikel Jan 27

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...
Analyseartikel Jan 12

Revenues Tell The Story For Ambu A/S (CPH:AMBU B) As Its Stock Soars 27%

Ambu A/S ( CPH:AMBU B ) shareholders would be excited to see that the share price has had a great month, posting a 27...
Analyseartikel Dec 31

Is It Too Late To Consider Buying Ambu A/S (CPH:AMBU B)?

Ambu A/S ( CPH:AMBU B ), is not the largest company out there, but it received a lot of attention from a substantial...
User avatar
Neues Narrativ Dec 16

Innovative aScope 5 Uretero And Sustainable Initiatives Will Accelerate Revenue Growth

Strategic focus on new high-value product launches and sustainability efforts could enhance revenue growth, product adoption, and brand perception while supporting long-term profitability.
Analyseartikel Nov 28

Here's Why It's Unlikely That Ambu A/S' (CPH:AMBU B) CEO Will See A Pay Rise This Year

Key Insights Ambu will host its Annual General Meeting on 4th of December CEO Britt Jensen's total compensation...
Analyseartikel Nov 13

Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

Ambu A/S ( CPH:AMBU B ) just reported healthy earnings but the stock price didn't move much. Our analysis suggests that...
Analyseartikel Nov 07

Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts

Shareholders might have noticed that Ambu A/S ( CPH:AMBU B ) filed its full-year result this time last week. The early...
Analyseartikel Sep 02

Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next

It's been a sad week for Ambu A/S ( CPH:AMBU B ), who've watched their investment drop 10% to kr.128 in the week since...
Analyseartikel Aug 06

Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...
Analyseartikel Apr 06

Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

With a median price-to-sales (or "P/S") ratio of close to 6.1x in the Medical Equipment industry in Denmark, you could...
Analyseartikel Mar 14

Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to...
Analyseartikel Feb 01

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Investors in Ambu A/S ( CPH:AMBU B ) had a good week, as its shares rose 2.9% to close at kr.115 following the release...
Analyseartikel Jan 02

A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

It's not a stretch to say that Ambu A/S' ( CPH:AMBU B ) price-to-sales (or "P/S") ratio of 5.9x right now seems quite...
Analyseartikel Oct 31

Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Key Insights Ambu's estimated fair value is kr.114 based on 2 Stage Free Cash Flow to Equity Ambu's kr.66.00 share...

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: AMBU B zahlt keine nennenswerte Dividende für den Markt Danish, daher muss nicht geprüft werden, ob die Zahlungen stabil sind.

Wachsende Dividende: AMBU B zahlt keine nennenswerte Dividende für den Markt Danish, daher ist es nicht notwendig zu prüfen, ob die Zahlungen steigen.


Dividendenrendite im Vergleich zum Markt

Ambu Dividendenrendite im Vergleich zum Markt
Wie sieht die Dividendenrendite von AMBU B im Vergleich zum Markt aus?
SegmentDividendenrendite
Unternehmen (AMBU B)0.6%
Untere 25 % des Marktes (DK)1.6%
Markt Top 25 % (DK)4.2%
Branchendurchschnitt (Medical Equipment)2.3%
Analystenprognose (AMBU B) (bis zu 3 Jahre)1.1%

Bemerkenswerte Dividende: AMBU BDie Dividende des Unternehmens (0.61%) ist im Vergleich zu den unteren 25 % der Dividendenzahler auf dem Markt Danish (1.62%) nicht bemerkenswert.

Hohe Dividende: AMBU BDie Dividende des Unternehmens (0.61%) ist im Vergleich zu den besten 25% der Dividendenzahler auf dem Markt Danish (4.2%) niedrig.


Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: AMBU B zahlt keine nennenswerte Dividende für den Markt Danish.


Barausschüttung an die Aktionäre

Cashflow-Deckung: AMBU B zahlt keine nennenswerte Dividende für den Markt Danish.


Entdecken Sie dividendenstarke Unternehmen

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/21 16:55
Aktienkurs zum Tagesende2026/05/21 00:00
Gewinne2026/03/31
Jährliche Einnahmen2025/09/30

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Ambu A/S wird von 14 Analysten beobachtet. 8 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
null nullABG Sundal Collier
Michael HealyBerenberg
Susannah LudwigBernstein